Avacta Group (LON:AVCT) Share Price Passes Above 200 Day Moving Average – What’s Next?

Avacta Group Plc (LON:AVCT) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 62.96 and traded as high as GBX 63. Avacta Group shares last traded at GBX 61.80, with a volume of 1,387,950 shares traded.

Avacta Group Price Performance

The company has a market cap of £270.82 million, a price-to-earnings ratio of -3.53 and a beta of 1.12. The company has a current ratio of 0.79, a quick ratio of 4.96 and a debt-to-equity ratio of 14,168.75. The business has a 50-day moving average price of GBX 57.54 and a 200 day moving average price of GBX 62.96.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).